robosep cd4 + naïve t cell negative selection kit (STEMCELL Technologies Inc)
Structured Review
![Panels A-C) primary <t>CD4</t> + T-cells were activated with α-CD3-CD28 beads and infected with HIV-1 pNL4-3 or mock-infected. Cells were cultured for two weeks post-infection (p.i.) to model different infection stages (days 3-9 p.i., i . e . productive infection; day 14 p.i., i . e . latent infection) and subjected to microarray (A,B; n=2) or RNA-Seq (C; n=3) analysis. Panel A) Gene set enrichment analysis (GSEA) of the expression of the glycolytic pathway (HUMAN-GLYCOLYSIS) in mock-infected or HIV-1 infected cells. B,C) Heatmaps of the relative expression of glycolytic enzymes upon HIV-1 infection. Data are expressed as Log 2 fold change in HIV-1 infected vs mock-infected cells. For microarray data (B) expression values of infected and mock-infected cells at different time points were pooled. For RNA-Seq data (C), expression values in infected cells were normalized using the corresponding time point in mock-infected cells. Adjusted p values (q values) to account for multiple testing were calculated by Significance Analysis of Microarrays [SAM ( Tusher et al , 2001 )] and Deseq2 for RNA-Seq data ( Love et al , 2014 ). Panels D-F) scRNA-Seq of the expression of the entire glycolytic pathway or of glucose phosphate isomerase only ( GPI ) in primary CD4 + T-cells infected in vitro (D,E) or CD4 + T-cells of PLWH (F). In panels D,E, cells were infected with VSVG-HIV-1-GFP and sorted for viral expression as detailed in ( Golumbeanu et al , 2018 ). Following latency establishment, cells were left untreated or HIV-1 expression was reactivated through suberoyl anilide hydroxamic acid (SAHA) or α-CD3-CD28 engagement. Clusters 1 and 2 were identified by principal component analysis as described in ( Golumbeanu et al , 2018 ). In panel F, CD4 + T-cells were isolated from total blood of PLWH under ART as described in ( Cohn et al , 2018 ). Viral expression was reactivated by treatment with phytohemagglutinin (PHA) and cells were sorted using antibodies against Env and Gag. Sorted cells were then subjected to scRNA-Seq analysis. The expression level of the HUMAN-GLYCOLYSIS pathway in Panel D was calculated as the average expression of genes comprising the gene list; expression levels in cluster 1 and 2 were compared using Wilcoxon rank sum test. For panels E-F significance of GPI differential expression level between clusters (E) or between control and Env + Gag + conditions (F) was assessed by Wilcoxon rank sum test encoded in FindMarkers Seurat R function. Panels G,H) Correlation of combined HIV-1 expression and the expression of the entire glycolytic pathway (G) or GPI only (H) in sc-RNA-Seq profiling of untreated HC69 microglial cells. Data were analyzed by Spearman’s correlation coefficients. ** p< 0.01, *** p< 0.001; *** p< 0.0001.](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_10/10__1101_slash_2020__12__30__424810/10__1101_slash_2020__12__30__424810___F1.large.jpg)
Robosep Cd4 + Naïve T Cell Negative Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/robosep+cd4+++na%C3%AFve+t+cell+negative+selection+kit/bio_rxiv__2020__12__30__424810-159-10-19?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress"
Article Title: Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress
Journal: bioRxiv
doi: 10.1101/2020.12.30.424810
Figure Legend Snippet: Panels A-C) primary CD4 + T-cells were activated with α-CD3-CD28 beads and infected with HIV-1 pNL4-3 or mock-infected. Cells were cultured for two weeks post-infection (p.i.) to model different infection stages (days 3-9 p.i., i . e . productive infection; day 14 p.i., i . e . latent infection) and subjected to microarray (A,B; n=2) or RNA-Seq (C; n=3) analysis. Panel A) Gene set enrichment analysis (GSEA) of the expression of the glycolytic pathway (HUMAN-GLYCOLYSIS) in mock-infected or HIV-1 infected cells. B,C) Heatmaps of the relative expression of glycolytic enzymes upon HIV-1 infection. Data are expressed as Log 2 fold change in HIV-1 infected vs mock-infected cells. For microarray data (B) expression values of infected and mock-infected cells at different time points were pooled. For RNA-Seq data (C), expression values in infected cells were normalized using the corresponding time point in mock-infected cells. Adjusted p values (q values) to account for multiple testing were calculated by Significance Analysis of Microarrays [SAM ( Tusher et al , 2001 )] and Deseq2 for RNA-Seq data ( Love et al , 2014 ). Panels D-F) scRNA-Seq of the expression of the entire glycolytic pathway or of glucose phosphate isomerase only ( GPI ) in primary CD4 + T-cells infected in vitro (D,E) or CD4 + T-cells of PLWH (F). In panels D,E, cells were infected with VSVG-HIV-1-GFP and sorted for viral expression as detailed in ( Golumbeanu et al , 2018 ). Following latency establishment, cells were left untreated or HIV-1 expression was reactivated through suberoyl anilide hydroxamic acid (SAHA) or α-CD3-CD28 engagement. Clusters 1 and 2 were identified by principal component analysis as described in ( Golumbeanu et al , 2018 ). In panel F, CD4 + T-cells were isolated from total blood of PLWH under ART as described in ( Cohn et al , 2018 ). Viral expression was reactivated by treatment with phytohemagglutinin (PHA) and cells were sorted using antibodies against Env and Gag. Sorted cells were then subjected to scRNA-Seq analysis. The expression level of the HUMAN-GLYCOLYSIS pathway in Panel D was calculated as the average expression of genes comprising the gene list; expression levels in cluster 1 and 2 were compared using Wilcoxon rank sum test. For panels E-F significance of GPI differential expression level between clusters (E) or between control and Env + Gag + conditions (F) was assessed by Wilcoxon rank sum test encoded in FindMarkers Seurat R function. Panels G,H) Correlation of combined HIV-1 expression and the expression of the entire glycolytic pathway (G) or GPI only (H) in sc-RNA-Seq profiling of untreated HC69 microglial cells. Data were analyzed by Spearman’s correlation coefficients. ** p< 0.01, *** p< 0.001; *** p< 0.0001.
Techniques Used: Infection, Cell Culture, Microarray, RNA Sequencing, Expressing, In Vitro, Isolation, Quantitative Proteomics, Control
Figure Legend Snippet: Panels A,B. Reactivation from HIV-1 latency (A) and relative cell viability (B) in different cell models following treatment with the Trx inhibitor auranofin (AF; 500 nM), the GSH inhibitor buthionine sulfoximine (BSO; 250 μM), or a combination of the two. The characteristics of the different models adopted are detailed in the Material and Methods section. Each data point represents a mean from at least two independent experiments conducted in the different models. Replicates of all experiments for each cell model are shown in Additional Files 8, 9 and 11, except for the data of monocyte-derived macrophages which were retrieved from ( Shytaj et al , 2013 ). Panel C. Levels of integrated HIV-1 DNA following treatment for 48 h with AF and/or BSO in CD4 + T-cells derived from PLWH under suppressive antiretroviral therapy. Live cells were sorted after treatment, and integrated DNA was measured by Alu-PCR. The latency reactivating agent SAHA was used as a reference compound ( Archin et al , 2012 ). Data were analyzed by non-parametric Friedman’s test followed by Dunn’s post-test (A,C) or two-way ANOVA followed by Tukey’s post-test (B). Solid lines represent the means. * p< 0.05, ** p< 0.01, *** p< 0.001.
Techniques Used: Derivative Assay